Hematology TimesInhibitor could treat range of hematologic disordersJuly 29, 2015CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic SyndromeCML
Hematology TimesAnalysis reveals potential therapeutic target for AMLJuly 24, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesGroup creates mouse model of RUNX1-mutated AMLJuly 20, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsEHA: High-risk APL curable with chemo-free comboJuly 18, 2015AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsClonal hematopoiesis explored in aplastic anemiaJuly 1, 2015AMLAnemiaMyelodysplastic Syndrome
Hematology TimesJury still out on combo for elderly AMLJune 20, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesDrug may be ‘important treatment option’ for AMLJune 18, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesAvocado-derived compound could treat AMLJune 17, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesIDH1 inhibitor gets orphan designation for AMLJune 12, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesPathway may play key role in FLT3-ITD AMLJune 11, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesA better FLT3 inhibitor for AML?June 10, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsCD8 cell dose predicts outcomes in allogeneic stem cell transplantation with reduced-intensity conditioningJune 8, 2015Myelodysplastic SyndromeLymphoma & Plasma Cell DisordersAMLCellular Therapy
Hematology TimesLSC phenotypes correlate with prognosis in AMLJune 4, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesDART molecule proves active against AMLMay 29, 2015Leukemia, Myelodysplasia, TransplantationAML
Oncology PracticeDexrazoxane Tx did not affect overall survival in pediatric leukemia and lymphomaMay 26, 2015Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
